H. E. Hobbs
Impact in
- Ophthalmology top 1%
- Drug-Induced Ocular Toxicity
- Ocular Diseases and Behçet’s Syndrome
- Retinal Diseases and Treatments
- Retinal and Optic Conditions
- Glaucoma and retinal disorders
- Ocular Infections and Treatments
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
Papers in
-
- Drug-Induced Ocular Toxicity 5
- Glaucoma and retinal disorders 2
-
- Systemic Lupus Erythematosus Research 5
- Co-authors
- A. Freedman (1 shared paper)Arnold Sorsby (1 shared paper)C. D. Calnan (1 shared paper)Nicholas J. Ashton (1 shared paper)D. P. Choyce (1 shared paper)G. du Boulay (1 shared paper)Richard E. Davis (1 shared paper)D. J. Harman (1 shared paper)
- Journals
- British Journal of Ophthalmology (9 papers)The Lancet (2 papers)Leprosy Review (2 papers)American Journal of Ophthalmology (1 paper)Eye (1 paper)
- Partner nations
- United KingdomMexicoGhana
In The Last Decade
H. E. Hobbs
19 papers receiving 423 citations
H. E. Hobbs's Hit Papers
Peers
Comparison fields: 5 of 70
- Ophthalmology 429
- Rheumatology 232
- Dermatology 31
- Pharmacology 31
- Neurology 42
Countries citing papers authored by H. E. Hobbs
This map shows the geographic impact of H. E. Hobbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. E. Hobbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. E. Hobbs more than expected).
Fields of papers citing papers by H. E. Hobbs
This network shows the impact of papers produced by H. E. Hobbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. E. Hobbs. The network helps show where H. E. Hobbs may publish in the future.
Co-authors
The 14 scholars most cited alongside H. E. Hobbs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RETINOPATHY FOLLOWING CHLOROQUINE THERAPY Hit paper breakdown → | 1959 | 294 |
| 2 | 1961 | 122 | |
| 3 | 1958 | 79 | |
| 4 | 1959 | 28 | |
| 5 | 1952 | 28 | |
| 6 | 1971 | 18 | |
| 7 | 1960 | 17 | |
| 8 | 1953 | 9 | |
| 9 | 1978 | 9 | |
| 10 | 2010 | 5 | |
| 11 | 1954 | 5 | |
| 12 | 1954 | 4 | |
| 13 | 1963 | 4 | |
| 14 | 1961 | 4 | |
| 15 | 1961 | 3 | |
| 16 | 1962 | 2 | |
| 17 | 1966 | 2 | |
| 18 | 1963 | 1 | |
| 19 | 1963 | 1 | |
| 20 | 1964 | 0 |
About H. E. Hobbs
H. E. Hobbs is a scholar working on Ophthalmology, Rheumatology, Surgery, Molecular Biology and Genetics, having authored 21 papers that have together received 635 indexed citations. Recurring topics across this work include Drug-Induced Ocular Toxicity (5 papers), Systemic Lupus Erythematosus Research (5 papers), Vascular Malformations and Hemangiomas (3 papers), Retinoids in leukemia and cellular processes (2 papers), Glaucoma and retinal disorders (2 papers), Acne and Rosacea Treatments and Effects (2 papers), Connexins and lens biology (2 papers) and Leprosy Research and Treatment (2 papers). The work is most often cited by research in Ophthalmology (429 citations), Rheumatology (232 citations), Dermatology (31 citations), Pharmacology (31 citations) and Neurology (42 citations). H. E. Hobbs has collaborated with scholars based in United Kingdom, Mexico and Ghana. Frequent co-authors include A. Freedman, Arnold Sorsby, C. D. Calnan, Nicholas J. Ashton, D. P. Choyce, G. du Boulay, Richard E. Davis, D. J. Harman, A. C. McDOUGALL and A. G. Beckett. Their work appears in journals such as British Journal of Ophthalmology, The Lancet, Leprosy Review, American Journal of Ophthalmology and Eye.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.